Condensed Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net loss	$ (933,000)	$ (546,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	87,000	91,000
Amortization of debt issuance costs	132,000	34,000
Provision for bad debts	(1,000)	(16,000)
Provision for slow moving and obsolete inventory	138,000	68,000
Share-based payment expense	79,000	93,000
Changes in:
Accounts receivable	(141,000)	(344,000)
Inventory	258,000	92,000
Prepaid expenses and other current assets	(13,000)	(21,000)
Accounts payable	(253,000)	394,000
Accrued expenses and other current liabilities	108,000	(1,000)
Wages payable	34,000	26,000
Other assets	0	3,000
Other liabilities	0	2,000
Net cash used in operating activities	(505,000)	(125,000)
Cash flows from investing activities:
Purchase of property, plant and equipment	(30,000)	(12,000)
Patent application costs	(3,000)	(23,000)
Net cash used in investing activities	(33,000)	(35,000)
Cash flows from financing activities:
Payments on debt financing	(117,000)	(201,000)
Debt issuance costs	(130,000)	(50,000)
Proceeds from bridge loan	0	150,000
Proceeds from equipment loan	0	0
Proceeds from Lines of Credit	8,661,000	7,087,000
Payments on line of credit	(7,902,000)	(6,919,000)
Net cash provided by financing activities	512,000	67,000
Net decrease in cash and cash equivalents	(26,000)	(93,000)
Cash and cash equivalents - beginning of period	89,000	93,000
Cash and cash equivalents - end of period	63,000	0
Supplemental disclosures of cash flow information
Cash paid during period for interest	198,000	152,000
Cash paid for taxes	0	0
Non cash financing activities - equity based debt costs	$ 282,000	$ 0